Effects of QuetiapineXR in schizophrenic patients with cannabis abuse and/or cannabis induced psychosis -pilot study.

Trial Profile

Effects of QuetiapineXR in schizophrenic patients with cannabis abuse and/or cannabis induced psychosis -pilot study.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 24 Nov 2012

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Apr 2012 Official Title amended as reported by European Clinical Trials Database record.
    • 28 Apr 2012 Planned number of patients 30 added as reported by Clinical Trials Databaserecord.
    • 28 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-000766-23).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top